We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SRRK market cap is 4.21B. The company's latest EPS is USD -1.7710 and P/E is -24.62.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -39.08M | -43.67M | -48.03M | -58.42M | -59.5M |
Net Income | -37.93M | -42.36M | -46.13M | -56.85M | -58.51M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 20.49M | 15.4M | 18.82M | 33.19M | 0 |
Operating Income | -54.54M | -86.88M | -129.92M | -134.37M | -171.3M |
Net Income | -51M | -86.48M | -131.8M | -134.5M | -165.79M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 284.9M | 250.69M | 311.04M | 267.29M | 226.87M |
Total Liabilities | 82.4M | 83.02M | 85.82M | 84.51M | 93.25M |
Total Equity | 202.5M | 167.67M | 225.22M | 182.77M | 133.62M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 196.38M | 388.31M | 304.45M | 358.17M | 311.04M |
Total Liabilities | 83.48M | 127.54M | 132.37M | 97.93M | 85.82M |
Total Equity | 112.9M | 260.77M | 172.07M | 260.24M | 225.22M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -75.6M | -107.88M | -145.23M | -49.79M | -98.98M |
Investing | 74.74M | 66.27M | 41.14M | 33.38M | 84.01M |
Financing | 5.77M | 6.05M | 102.57M | 6.53M | 6.49M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -63.12M | -60.27M | -126.79M | -132.69M | -145.23M |
Investing | -62.24M | -63.5M | 134.32M | -171.7M | 41.14M |
Financing | 48.88M | 247.82M | 44.95M | 194.83M | 102.57M |
Market Cap | 4.21B |
Price to Earnings Ratio | -24.62 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 40.08 |
Price to Book Ratio | 18.13 |
Dividend Yield | - |
Shares Outstanding | 93.61M |
Average Volume (1 week) | 947.33k |
Average Volume (1 Month) | 1.23M |
52 Week Change | 190.32% |
52 Week High | 45.00 |
52 Week Low | 6.76 |
Spread (Intraday) | 5.33 (11.84%) |
Company Name | Scholar Rock Holdings Corporation |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.scholarrock.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions